| Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine C Xue, Q Chu, Q Zheng, S Jiang, Z Bao, Y Su, J Lu, L Li Signal transduction and targeted therapy 7 (1), 142, 2022 | 30 | 2022 |
| Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes X Gu, J Guan, J Xu, Q Zheng, C Chen, Q Yang, C Huang, G Wang, ... Journal of translational medicine 19, 1-13, 2021 | 25 | 2021 |
| TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers QX Zheng, J Wang, X Gu, CH Huang, C Chen, M Hong, Z Chen Biomedicine & Pharmacotherapy 135, 111169, 2021 | 23 | 2021 |
| The Nrf2 pathway in liver diseases J Zhou, Q Zheng, Z Chen Frontiers in Cell and Developmental Biology 10, 2022 | 21 | 2022 |
| HAND2-AS1: A functional cancer-related long non-coding RNA X Gu, Q Zheng, Q Chu, H Zhu Biomedicine & Pharmacotherapy 137, 111317, 2021 | 20 | 2021 |
| Immune checkpoint targeting TIGIT in hepatocellular carcinoma Q Zheng, J Xu, X Gu, F Wu, J Deng, X Cai, G Wang, G Li, Z Chen American Journal of Translational Research 12 (7), 3212, 2020 | 20 | 2020 |
| The dual functions of the long noncoding RNA CASC15 in malignancy X Gu, Q Chu, Q Zheng, J Wang, H Zhu Biomedicine & Pharmacotherapy 135, 111212, 2021 | 18 | 2021 |
| The functional roles of the circRNA/Wnt axis in cancer C Xue, G Li, Q Zheng, X Gu, Z Bao, J Lu, L Li Molecular Cancer 21 (1), 1-24, 2022 | 15 | 2022 |
| Long noncoding RNA SNHG4: a novel target in human diseases Q Chu, X Gu, Q Zheng, Z Guo, D Shan, J Wang, H Zhu Cancer Cell International 21 (1), 1-13, 2021 | 15 | 2021 |
| Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions Q Zheng, Q Yang, J Zhou, X Gu, H Zhou, X Dong, H Zhu, Z Chen Cancer cell international 21, 1-14, 2021 | 14 | 2021 |
| Uncovering the Association Between m5C Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in … X Gu, H Zhou, Q Chu, Q Zheng, J Wang, H Zhu Frontiers in cell and developmental biology 9, 727935, 2021 | 12 | 2021 |
| Regulatory mechanism of HIF-1α and its role in liver diseases: A narrative review Q Chu, X Gu, Q Zheng, H Zhu Annals of Translational Medicine 10 (2), 2022 | 11 | 2022 |
| Mitochondrial mechanisms of apoptosis and necroptosis in liver diseases Q Chu, X Gu, Q Zheng, J Wang, H Zhu Analytical Cellular Pathology 2021, 1-9, 2021 | 11 | 2021 |
| Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma J Jiang, Q Zheng, W Zhu, X Chen, H Lu, D Chen, H Zhang, M Shao, ... Aging (Albany NY) 12 (11), 10300, 2020 | 11 | 2020 |
| The emerging role of thymopoietin-antisense RNA 1 as long noncoding RNA in the pathogenesis of human cancers Q Zheng, J Jia, Z Zhou, Q Chu, W Lian, Z Chen DNA and Cell Biology 40 (7), 848-857, 2021 | 9 | 2021 |
| DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression Q Zheng, X Gu, Q Yang, Q Chu, Y Dai, Z Chen Clinica Chimica Acta 517, 1-8, 2021 | 9 | 2021 |
| Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma Q Zheng, Q Fu, J Xu, X Gu, H Zhou, C Zhi Journal of Cancer 12 (6), 1792, 2021 | 8 | 2021 |
| Early use of dexamethasone increases Nr4a1 in Kupffer cells ameliorating acute liver failure in mice in a glucocorticoid receptor-dependent manner J Deng, Q Yang, X Cai, J Zhou, E Wei-Gao, Y An, Q Zheng, M Hong, ... Journal of Zhejiang University. Science. B 21 (9), 727, 2020 | 7 | 2020 |
| Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma C Xue, J Jia, X Gu, L Zhou, J Lu, Q Zheng, Y Su, S Zheng, L Li Signal Transduction and Targeted Therapy 7 (1), 335, 2022 | 4 | 2022 |
| Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors Z Bao, Q Zheng, L Li American Journal of Translational Research 13 (2), 757, 2021 | 4 | 2021 |
